Table 1.
Characteristics | No. (%) |
---|---|
Gender | |
Male | 886 (24.0) |
Female | 2800 (76.0) |
Age (Year) | |
Median (IQR) | 45 (35–55) |
<55 | 2758 (74.8) |
≥55 | 928 (25.2) |
Pathological Subtype | |
Classic | 3492 (94.7) |
Follicular variant | 169 (4.6) |
Other | 25 (0.7) |
Tumor Size (mm) | |
Median (IQR) | 6 (4–9) |
≤6.5 | 1982 (53.8) |
>6.5 | 1704 (46.2) |
CLT | |
Absent | 2395 (65.0) |
Present | 1291 (35.0) |
Multifocality | |
Absent | 2699 (73.2) |
Present | 987 (26.8) |
Bilaterality | |
Absent | 3021 (82.0) |
Present | 665 (18.0) |
ETE | |
Absent | 2779 (75.4) |
Present | 907 (24.6) |
LVI | |
Absent | 3626 (98.4) |
Present | 60 (1.6) |
T Stage | |
T1a | 3628 (98.4) |
T3b | 30 (0.8) |
T4a | 28 (0.8) |
N Stage | |
N0 | 2510 (68.1) |
N1a | 920 (25.0) |
N1b | 256 (6.9) |
M Stage | |
M0 | 3860 (99.8) |
M1 | 6 (0.2) |
Abbreviations: IQR, interquartile range; CLT, chronic lymphocytic thyroiditis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.